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same cells reveal tumor-derived vessel-like structures near necrotic areas, consistent 
ZLWKZLGHVSUHDGWXPRUGHULYHGHQGRWKHOLDOH[SUHVVLRQLQSULPDU\JOLRPDWLVVXH
&RQFOXVLRQV2XU¿QGLQJVVXSSRUWVWXGLHVLQGLFDWLQJWKDWWXPRUGHULYHGHQGRWKHOLDO





The rationale for current anti-angiogenic strategies 
in high-grade glioma is based upon the targeting of 
endothelial cells that are recruited from surrounding 
vascular networks or induced via sprouting of pre-existing 
vessels. Vascular endothelial growth factor (VEGF), a 
canonical master regulator of angiogenesis, has been 
regarded as a common effector of several angiogenic 
pathways and the anti-VEGF monoclonal antibody 
bevacizumab (Avastin) is one of few agents to progress 
to phase III trials. However, whilst the phase II clinical 
results of VEGF blockade in patients were promising [1, 
2], the outcomes of phase III trials have been disappointing 
ZLWKQREHQH¿WWRRYHUDOOVXUYLYDO>@7KHDVVXPSWLRQ
of a genetically stable endothelial phenotype in GBM has 
recently been challenged with evidence of tumor-derived 
endothelial cells (TDEC), which differ from but can 
integrate with recruited endothelial cells [5-7]. TDEC are 
genetically dysregulated cells, which derive from a process 
intrinsic to the tumor cell termed vasculogenic mimicry 
(VM) [8]. VM was initially described in melanoma but has 
been observed in leukemia and several solid neoplasms 
including prostate cancer and glioblastoma (GBM) [9-
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11]. VM-derived vessels constitute extracellular matrix 
(ECM)-rich networks lined by tumor cells. Xenografts 




Further investigation of VM and the processes that 
control this cellular behavior [12] will be greatly aided 
by an ability to simulate this process in vitro without the 
QHHGIRUDQDUWL¿FLDO(&0VXEVWUDWHZKLFKZLOOOHDGWRD
more comprehensive understanding of the environmental 
conditions and molecular pathways that promote the 
adoption of this strategy by cancer cells.
There is a growing recognition conceptually that 
WKUHHGLPHQVLRQDO ' FXOWXUH WHFKQRORJLHV PD\ PRUH
DFFXUDWHO\UHÀHFWWXPRUSDWKRSK\VLRORJ\DQGUHFDSLWXODWH
the in vivo tumor microenvironment in vitro, particularly 
for complex processes such as VM. One method of 
JHQHUDWLQJ'DJJUHJDWHVLQDQRQWXUEXOHQWHQYLURQPHQW
where cells secrete endogenous ECM and growth 
factors is the Rotary Cell Culture System (RCCSTM), 
originally developed by the National Aeronautics and 
Space Administration (NASA) to study the effects of 
PLFURJUDYLW\RQFHOOVDQGWLVVXHV>@:HKDYHSUHYLRXVO\
demonstrated that the RCCS can recapitulate brain tumor 
molecular heterogeneity and the hypoxic gradient of 
SULPDU\EUDLQWXPRUV>@+HUHZHLQYHVWLJDWHZKHWKHUWKH
VM process and the glioma-derived angiogenic response 
can be characterized and manipulated in the RCCS, thus 
presenting a model for in vitro pharmacological studies 
aimed at disrupting this potentially important component 
of tumor growth.
RESULTS
High-grade glioma (HGG) and ependymoma 
cells express endothelial markers in dynamic 3D 
culture
:HK\SRWKHVL]HGWKDW5&&6FXOWXUHZRXOGLQGXFH
endothelial-like protein expression in glioma cells in the 
absence of any endothelial cells or endothelial-promoting 
media. Primary HGG explant tissue exhibited distinct 
expression of the immature endothelial marker CD105 
(endoglin) (Figure 1A) in blood vessel structures within 
GD\VJURZWKZLWKLQWKH5&&6:HKDYHVKRZQKHUH
DQGSUHYLRXVO\>@WKDWPDFURVFRSLF5&&6DJJUHJDWHV
(~0.5 cm  0.75 cm diameter) can generate intrinsic 
hypoxic gradients whereby hypoxic glioma cells with 
low proliferative activity arise in peri-necrotic regions 
surrounding the aggregate core (Figure 1B). Cells 
at the interface between the hypoxic core and viable 
proliferative rim of aggregates expressed the endothelial 
FHOOPHPEUDQRXVPDUNHU&'LQ5&&6'WXPRURQO\
FXOWXUHVRIWKHSULPDU\FHOOOLQH*%DQGLQ.16DQG
U87 cell line-derived HGG aggregates (Figure 1C-1E).
A marked proportion of CD105 positive cells 
were also co-positive for GFAP (Figure 1F). Co-staining 
RI &'  +,)Į D PDUNHU RI K\SR[LF DGDSWDWLRQ
demonstrated co-localization in the core region (hypoxic 




positive cells typically located at the rim / core interface 
regions (Figure 1H). 
Tumor-derived endothelial marker expression was 
not restricted to GBM cells as aggregates of the primary 
ependymoma cell line Res196 also exhibited CD105 
H[SUHVVLRQ )LJXUH , 1HLWKHU &' QRU &' ZDV
H[SUHVVHGLQ.16RU8'PRQROD\HUFHOOVDIWHU
hours culture (Supplementary Figure 2A-2D). Prominent 
H[SUHVVLRQRIWKHPDWXUHHQGRWKHOLDOPDUNHU&'ZDV
observed surrounding tubular-like structures in U87 
aggregates (Figure 1J and Supplementary Figure 1B for 
ZLGH¿HOGYLHZRIZKROH5&&6DJJUHJDWHZKLFKZHUH
yet distinct from canonical vessels surrounded by GFAP 
positive tumour cells in primary HGG tissue. Collectively 
WKHVH ¿QGLQJV LQGLFDWH WKDW D 'LQGXFHG WXPRXU
PLFURHQYLURQPHQW LV VXI¿FLHQW WR SURPRWH H[SUHVVLRQ
RIWKHHQGRWKHOLDOPDUNHUV&'&'DQGY:)LQD
proportion of high grade glioma and ependymoma cells 
that reside in distinct tumour aggregate regions.
Tumor-derived angiogenic response in the RCCS 
better recapitulates primary glioma angiogenic 
H[SUHVVLRQSUR¿OHV
$UUD\ TXDQWLWDWLYH 573&5 SHUIRUPHG IRU 
DQJLRJHQHVLVUHODWHGJHQHVUHYHDOHGWKDW.16DQG8
*%05&&6DJJUHJDWHVH[KLELWHGVLJQL¿FDQWXSUHJXODWLRQ
of many angiogenic genes relative to corresponding 
monolayer cultures including FGF1, VEGFR1, VEGFC, 
$1*37&'+*)&;&/7*)ȕ5DQG,*)p 
< 0.001), whilst THBS1, an anti-angiogenic mediator 
was downregulated (p < 0.001) (Figure 2A-2B and 
Supplementary Tables 1 and 2). GB-1 HGG aggregates 
VKRZHGVLJQL¿FDQWXSUHJXODWLRQRIIRXUJHQHVLQFOXGLQJ
FGF2 and ANGPT1 (p < 0.001), though many more 
genes were upregulated but did not achieve statistical 
VLJQL¿FDQFH)LJXUH&'7RGHWHUPLQHWKHUHVHPEODQFH
to angiogenic response in primary tumors, GB-1 RCCS 
aggregates and monolayer cultures were analyzed in 
comparison to the primary grade III glioma from which 
WKHFHOOVZHUHGHULYHG$OOJHQHVZHUHVLJQL¿FDQWO\GRZQ
regulated in 2D culture relative to the parental tumor, 
with the most differentially expressed markers including 
&'153)*)5DQG003p < 0.005) (Figure 
2E). Although many genes were downregulated in GB-1 
Oncotarget3www.impactjournals.com/oncotarget
'FXOWXUH UHODWLYH WR WKHSDUHQWDO WXPRU HJ)*)5
7*)ȕDQG7<03FHUWDLQJHQHVZHUHQRZXSUHJXODWHG
HJ )*) $1*37 DQG ()1$ $GGLWLRQDO JHQHV
ZHUH XSUHJXODWHG EXW GLG QRW DFKLHYH VLJQL¿FDQFH DQG
the overall pattern of angiogenic-related expression was 
PRUHVLPLODUEHWZHHQ'FXOWXUHDQGSDUHQWDOWXPRUWKDQ
between 2D culture and tumor (Figure 2F). Angiogenic 
gene expression was further compared between an 
adult GBM (T7/11) acquired directly from surgery and 
cultured as explant tissue in the RCCS and a monolayer 
FXOWXUHGHULYHGIURPWKLVWXPRUSDVVDJH6LJQL¿FDQW
upregulation of many angiogenic genes including 
003&;&/,/DQG,/pDQGVLJQL¿FDQW
downregulation of the anti-angiogenic genes THBS1 and 
THBS2 (p < 0.001) was observed in the explant compared 
to the monolayer, providing direct evidence that loss of 
Figure 1: Vascular gene expression in putative brain tumor-derived endothelial cells within RCCS aggregates in 
vitro. Immunological detection of CD105, CD31 and vWF endothelial markers in high grade glioma 3D aggregates. A. Distinct CD105 
expression (brown) in microvessel structures in primary high-grade glioma explant tissue. B. Hypoxic regions surrounding the necrotic core 
(denoted CRI8DJJUHJDWHVDUHLGHQWL¿HGXVLQJ+\SR[\SUREHEURZQK\SR[LFVWDLQLQJLVDEVHQWLQWKHGHQVHO\FHOOXODUSHULSKHUDOULP
(denoted R). C. GB-1 cells derived from primary high-grade glioma with membranous CD105 expression (brown) at the interface (denoted 
I) between densely cellular aggregate rim (denoted R) and necrotic core (denoted C). D..16FHOOVZLWKPHPEUDQRXV&'H[SUHVVLRQ
(brown). E. U87 cells with membranous CD105 expression (brown). F.&RORFDOL]DWLRQRI&'UHGZLWK*)$3JUHHQ LQ.16
cells. G.8FHOOVH[KLELWFRORFDOL]DWLRQRI&'UHGDQG+,)ĮJUHHQLQDJJUHJDWHFRUHVDQGLQORFDOL]HGUHJLRQVH.:LGHVSUHDG
Y:)H[SUHVVLRQDWWKHLQWHUIDFHdenoted I) between densely cellular aggregate rim (denoted R) and relatively sparser core (denoted C) of 
.16FHOOVI. Distinct CD105 expression in aggregate core (denoted C) and rim (denoted R) regions in Res196 ependymoma aggregates. 
Two aggregates shown that have been harvested and subsequently sectioned in close proximity to each other. J. U87 cells with distinct 
&'H[SUHVVLRQUHGDWWKHDJJUHJDWHULPFRUHLQWHUIDFHK.3URPLQHQW&'H[SUHVVLRQUHGLQFDQRQLFDOYHVVHOVVXUURXQGHGE\*)$3
positive tumour cells (green) in primary HGG tissue. Scale bar A, C, E-H, J-K = 25µm; D = 10µm; B and I = 200µm. All aggregates were 
cultured for 7-10 days within the RCCS.
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'VWUXFWXUHZDVDVVRFLDWHGZLWKDGHFUHDVHGDQJLRJHQLF
response in monolayers (Figure 2G and Supplementary 
7DEOH7RHVWDEOLVKDQ\LQÀXHQFHIURPEUDLQHQGRWKHOLDO
FHOOVLJQDOLQJDQJLRJHQLFH[SUHVVLRQLQ.16+%0(&
co-cultured tumor / endothelial aggregates were compared 
to tumor-only cultures. Many genes were downregulated 
LQWKHFRFXOWXUHLQFOXGLQJ9(*)5127&+)*)
)*) 7*)ȕ5 DQG 003V p < 0.001), with a few 
JHQHV XSUHJXODWHG VLJQL¿FDQWO\ LQFOXGLQJ &;&/ DQG
,')LJXUH+DQG6XSSOHPHQWDU\7DEOHLQGLFDWLQJ
an overall dampening of the glioma-derived angiogenic 
response in the presence of canonical brain endothelial 
cells.
Tumor-derived vascular markers are expressed in 
vivo and glioma patient tissue
7RFRQ¿UPWKDW90ZDVDSKHQRPHQRQIRXQGLQ
tumor development in vivo, U87 GBM cells (at identical 
passage to that of U87 RCCS culture) were cultured 
VXEFXWDQHRXVO\DVÀDQN[HQRJUDIWVLQQXGHPLFH:LWKLQ




such CD105 positive vessel-like structures, indicating that 
they were connected to and forming part of the functional 
mouse vasculature. In contrast, vessels at the periphery of 
the grafts in the peri-tumoural area were negative for both 
&'DQG&'KXPDQSURWHLQH[SUHVVLRQ)LJXUH&
To evaluate the contribution of VM to the peri-
vascular niche in human tumors, the co-expression of glial 
and endothelial markers was investigated in a cohort of 
primary pediatric HGG patients. A minority population of 
cells stained co-positive for the astrocytic marker GFAP 
DQGHQGRWKHOLDOPDUNHU&'RU&'VXJJHVWLQJWKDW
these may be TDEC within the tumor mass. Co-staining 
IRU*)$3&')LJXUH'(ZDVPRUHIUHTXHQWWKDQ
FRVWDLQLQJ IRU*)$3 &' )LJXUH)ZLWK&'
positive TDEC observed in the vicinity of peri-necrotic 
areas within the tumor. 
Glioma-derived endothelial marker expression 
may recapitulate an embryonic-like process in 
vitro
:H VRXJKW WR H[DPLQH ZKHWKHU QRQQHRSODVWLF
HPEU\RQLF VWHP FHOOV (6& RU OLQHDJH GH¿QHG QHXUDO
Figure 2: Brain tumor-derived angiogenic expression is upregulated in RCCS culture in vitro. Volcano plots of angiogenesis 
array quantitative RT-PCR with a log2 fold difference on x-axis and p-value on y-axis. Horizontal blue line represents a p-value of 0.05 
and vertical pink lines represent a fold change of +/- three. A.-C.$QJLRJHQLFJHQHH[SUHVVLRQEHWZHHQ'DQG'JOLRPDFXOWXUHVRI
.168DQG*%UHVSHFWLYHO\D. Box plot representation of volcano plot from C.FRPSDULQJJHQHH[SUHVVLRQRI*%'YHUVXV'
H[SUHVVLRQLOOXVWUDWLQJVLJQL¿FDQWXSUHJXODWLRQRI)*)DQG$1*37JHQHVLQ'FXOWXUH(DFKEDUUHSUHVHQWVRQHRIDQJLRJHQLFJHQHV
E.-F.$QJLRJHQLFJHQHH[SUHVVLRQLQ*%'DQG'FXOWXUHVUHVSHFWLYHO\UHODWLYHWRWKH+**SULPDU\WXPRUIURPZKLFKWKHFHOOOLQH
was derived. G. Differential angiogenic gene expression in primary GBM explant tissue relative to the 2D monolayer line T7 / 11 derived 
from this explant. H.'LIIHUHQWLDODQJLRJHQLFH[SUHVVLRQEHWZHHQ.16+%0(&KHWHURJHQHRXVDJJUHJDWHVDQG.16WXPRURQO\
aggregates. For all experiments, each dot represents the mean gene expression of one gene assayed in three independent RNA samples from 
WKUHHGLIIHUHQW'DJJUHJDWHVZLWKVHOHFWHGJHQHVRILQWHUHVWLGHQWL¿HGRQSORWV(DFKH[SHULPHQWDOFRQGLWLRQHJ'RU'LVSUHVHQWHG
relative to each other.
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stem cells (NSC) also had the capacity under appropriate 
cell culture conditions to exhibit endothelial-like 
characteristics. A proportion of glioma cells exhibit stem-
like characteristics and we hypothesized that VM may 
be a recapitulation of a stem-like behavior lost in non-
QHRSODVWLFOLQHDJHGH¿QHGFHOOV&'ZDVH[SUHVVHGLQD
proportion of mouse embryonic stem cells (ESC) cultured 
DV5&&6DJJUHJDWHV )LJXUH$ZKHUHDV&'ZDV
completely absent in neural stem cells (NSC) derived from 
SRVWQDWDOPLFHDQGFXOWXUHGLQ WKH5&&6)LJXUH%
Neural stem cells express three out of four genes required 
WRIRUPDSOXULSRWHQWFHOO>@WKHUHPDLQLQJJHQHHQFRGHV
WKHWUDQVFULSWLRQIDFWRU2&7ZKLFKKDVEHHQUHFHQWO\
implicated as a potential oncogene [22]. Interestingly, 
ZKHQ2&7ZDVFRQVWLWXWLYHO\RYHUH[SUHVVHGLQWKHVDPH
NSC line, CD105 expression became evident in sporadic 
FHOOV ZLWKLQ DJJUHJDWHV )LJXUH & &' ZDV DEVHQW
from all ESC and NSC aggregates (Supplementary Figure 
2E-2G). 
Tumor-derived angiogenic expression is 
downregulated upon VEGF / FGFR inhibition in 
vitro
Based on our angiogenesis array quantitative RT-
PCR data and existing glioma angiogenesis literature 
> @ ZH VHOHFWHG9(*) DQG )*)5 DV FDQGLGDWH
mediators of the angiogenic response, observed to 
EH VLJQL¿FDQWO\ XSUHJXODWHG LQ WKH 5&&6 UHODWLYH WR
Figure 3: Glioma tumor-derived endothelial marker expression in vivo. 6XEFXWDQHRXV KXPDQ 8 ÀDQN [HQRJUDIWV IURP
LPPXQRGH¿FLHQWPLFHZHUHDVVHVVHGIRUWXPRUGHULYHGHQGRWKHOLDOPDUNHUH[SUHVVLRQ A.&'KXPDQHSLWRSHH[SUHVVLRQEURZQVWDLQ
lining the wall of a vessel-like structure within the U87 xenograft. B. CD105 expression (brown stain) lining vessel-like structures within a 
xenografted tumor, containing visible erythrocytes (arrow). C. Mouse blood vessel from periphery of tumor graft containing erythrocytes 
EXWZLWKQRSRVLWLYH VWDLQLQJ IRU KXPDQVSHFL¿F&' ,PPXQRÀXRUHVFHQFHZDV FRQGXFWHG IRU WXPRU DQG HQGRWKHOLDOPDUNHUV LQ D
selection of pediatric HGG. D.-E. Merged image showing co-localization of CD105 (red) and GFAP (green) on putative TDEC in primary 
HGG tissue. F.&RORFDOL]DWLRQRI&'UHGDQG*)$3JUHHQLQSULPDU\+**WLVVXHScale bar A-C = 25µm; D-F = 20µm.
Figure 4: OCT4 overexpression in mouse NSC RCCS aggregates leads to CD105 expression. A. CD105 expression in mouse 




monolayer cultures (Supplementary Tables 1 and 2) 
.169(*)5IROG p)*)
fold (p89(*)5IROGp < 0.001), 
FGF2 +2.85-fold (p   .16 DQG 8 *%0
aggregates were exposed for three days to the VEGF 
competitive inhibitor CBO-P11 (Calbiochem), which 
blocks the binding of the VEGF ligand to its receptors 
VEGFR1 and VEGFR2 or the FGF receptor tyrosine 
kinase inhibitor PD166866 (Calbiochem), which acts 
DV D FRPSHWLWLYH LQKLELWRU RI WKH )*) OLJDQGV :H
YHUL¿HG WKH FRQFHQWUDWLRQV DW ZKLFK WKHVH LQKLELWRUV
negatively affected cell viability (Supplementary Figure 
DQGRQWKLVEDVLVVHOHFWHG09(*)LQKLELWRUDQG
0)*)5LQKLELWRUDVFRQFHQWUDWLRQVDWZKLFKDQWL
angiogenic phenotypes (down-regulation of angiogenic 
genes and disruption of vascular-like structures) could 
be distinguished without severe compromise to cell 
YLDELOLW\6XSSOHPHQWDU\)LJXUH0DQ\DQJLRJHQHVLV
UHODWHGJHQHVZHUHGRZQUHJXODWHGLQ.16DJJUHJDWHV
treated with either inhibitor when compared to untreated 
aggregates. Prominent amongst downregulated genes in 
UHVSRQVHWR9(*)SDWKZD\LQKLELWLRQZHUH7<03/(3
+*) &;&/ 003 9(*)5 DQG $1*37 p < 
0.001) (Figure 5A and Supplementary Table 5). Prominent 
.16 JHQHV VLJQL¿FDQWO\ GRZQUHJXODWHG LQ UHVSRQVH
WR )*)5 LQKLELWLRQ ZHUH 7<03 +*) 7(. &;&/
MMP9, VEGFR1, ANGPT1, FGF1 and FGF2 (p < 0.001) 
)LJXUH%DQG6XSSOHPHQWDU\7DEOH.16&'
DQG&'H[SUHVVLRQZDVVLJQL¿FDQWO\UHGXFHGUHODWLYH
to untreated aggregates upon both drug treatments (p < 
0.001), though with greater fold change reductions in 
UHVSRQVHWR)*)5LQKLELWLRQIRU&'DQG
IRU&'WKDQREVHUYHGIRU9(*)LQKLELWLRQIRU
&' DQG  IRU &'7ZR .16 JHQHV ZHUH
VLJQL¿FDQWO\ GRZQUHJXODWHG ZKHQ WUHDWPHQW ZLWK ERWK
DQWL)*)5 DQG DQWL9(*) DJHQWV ZDV FRPSDUHG ,/
and CDH5) (Supplementary Tables 5-6). Similarly, many 
genes were downregulated in U87 as a response to either 
DJHQWLQFOXGLQJJURZWKIDFWRUVDQGWKHHQGRWKHOLDOVSHFL¿F
TEK, a receptor for angiopoietin-1 known to be critical 
for normal vascular development (Figure 5C-5D). Several 
genes exhibited reduced expression in a similar manner 
WRWKDWREVHUYHGIRU.16HJ/(3+*)DQG7(.p 
< 0.001) and many U87 cytokines were downregulated 
in response to either drug, including the pro-angiogenic 
F\WRNLQHV&;&/&;&/&;&/DQG3)&;&/
Other notable downregulated genes included VEGFR1, 
7*)ȕ5 ,*) (5(* DQ (*)5 OLJDQG $1*37
and HGF (p < 0.001) and remodelers of the ECM such 
as MMP9 (p < 0.001) (Figure 5C-5D and Supplementary 
7DEOHV  &' ZDV VLJQL¿FDQWO\ GRZQUHJXODWHG
(p < 0.001) in response to either agent (-15.08 fold for 
anti-VEGF and -11.9 fold for anti-FGFR) but CD105 
H[SUHVVLRQ ZDV QRW VLJQL¿FDQWO\ DOWHUHG E\ HLWKHU GUXJ
in U87 aggregates. Notably, the VEGFR1 transcript 
ZDVVLJQL¿FDQWO\GRZQUHJXODWHGE\8LQUHVSRQVHWR
treatment with either drug (p < 0.001) (Supplementary 
Tables 7-8).
Vasculogenic mimicry is abrogated upon VEGF/
FGFR inhibition in vitro
Glioma aggregates treated with either the VEGF or 
FGFR inhibitor retained a similar morphologic appearance 
to untreated aggregates, with a pronounced core region 
of low cellular density relative to a peripheral rim of 
KLJKFHOOXODUGHQVLW\6XSSOHPHQWDU\)LJXUH.16
aggregates exhibited low expression of the proliferation 
PDUNHU.LLQUHVSRQVHWR)*)5LQKLELWLRQ
but retained foci of high Ki67 expression in response 
WR9(*)LQKLELWLRQ)LJXUH()8
aggregates exhibited an absence of actively proliferating 
.LFHOOVZKHQ)*)5ZDVLQKLELWHGEXW
retained sporadic proliferating Ki67 cells when VEGF 
ZDVLQKLELWHG)LJXUH*+([SRVXUHRI
.16DQG8DJJUHJDWHVWRHLWKHULQKLELWRUDWGRVHV
observed not to impair cell viability in monolayer culture, 
VHH6XSSOHPHQWDU\)LJXUHUHVXOWHGLQFRPSOHWHORVVRI
WXPRUGHULYHG&'DQG&'H[SUHVVLRQ)LJXUH
when compared to untreated cells (Figure 1D-1E and 1J). 
&ROOHFWLYHO\WKHVH¿QGLQJVLQGLFDWHWKDW7'(&REVHUYHG
in RCCS GBM aggregates is at least in part, dependent on 
9(*))*)5VLJQDOLQJ:KHUHDVODFNRI7'(&PD\EH
coupled to proliferation impairment upon VEGF inhibition 
LQ .16 DQG 8 5&&6 FXOWXUH 7'(& DEVHQFH LV
independent of proliferation impairment upon FGFR 
inhibition.
Glioma cells form endothelial-like tubules in a 
VEGF/FGFR-dependent manner in vitro
8QGHU ' FXOWXUH FRQGLWLRQV 0DWULJHO WKDW
SURPRWHDQHQGRWKHOLDOSKHQRW\SH.16JOLRPDFHOOV
(demonstrating an upregulated angiogenic response 
in RCCS cultures) were capable of generating distinct 
branching network structures characteristic of endothelial 
cells (Figure 7A). Branching structures were more 
pronounced under hypoxic strain, albeit the numbers 
RIWXEXOHVZHUHQRWVLJQL¿FDQWO\GLIIHUHQWp < 0.05) to 
that observed in normoxic cultures (Figure 7B). VEGF 
LQKLELWLRQUHVXOWHGLQPLOGEXWVLJQL¿FDQWLPSDLUPHQWWR
tubular structures, with fewer visible tubules relative to 
normoxic cultures (p < 0.05) (Figure 6C), whilst FGFR 
inhibition or dual VEGF / FGFR inhibition resulted in 
VHYHUHVLJQL¿FDQWLPSDLUPHQWRIFORVHGWXEXOHIRUPDWLRQ
(p < 0.01) (Figure 7D-7E). Exposure to DMSO alone did 
QRWOHDGWRDVLJQL¿FDQWFKDQJHp < 0.05) in branching 
QHWZRUN IRUPDWLRQ FRPSDUHG WR .16 FHOOV XQGHU
normoxia (Figure 7F). 
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Figure 5: Downregulation of tumor-derived angiogenic response upon VEGF or FGFR inhibition in vitro. Volcano plots 
of angiogenesis array quantitative RT-PCR with a log2 fold difference on x-axis and p-value on y-axis. Horizontal blue line represents 
a p-value of 0.05 and vertical pink lines represent a fold change of +/- three. Each dot represents the mean gene expression of one gene 
DVVD\HG LQ WKUHH LQGHSHQGHQW51$VDPSOHV IURP WKUHHGLIIHUHQW'DJJUHJDWHVZLWK VHOHFWHGJHQHV LGHQWL¿HGRQSORWVA.-B..16
DJJUHJDWHVWUHDWHGZLWKWKH&%239(*)LQKLELWRURU3')*)5LQKLELWRUUHVSHFWLYHO\UHODWLYHWRXQWUHDWHG.16DJJUHJDWHV
VKRZLQJVLJQL¿FDQWGRZQUHJXODWLRQRIPDQ\DQJLRJHQHVLVUHODWHGJHQHVLQWUHDWHGFHOOVC.-D. U87 aggregates treated with CBO-P11 and 
3'UHODWLYH WRXQWUHDWHG8DJJUHJDWHVUHVSHFWLYHO\VKRZLQJVLJQL¿FDQWGRZQUHJXODWLRQRIPDQ\JHQHV LQ WUHDWHGDJJUHJDWHV
Angiogenic gene expression depicted represents the mean of three independent experiments each run using triplicate arrays. E./RZOHYHOV
RIDFWLYHSUROLIHUDWLRQZLWKLQ.16DJJUHJDWHVWUHDWHGZLWK3'ZLWKRI.LSRVLWLYHFHOOVF./RFDOL]HGSDWFKHVRI




cells relative to total number of cells is given and representative images shown. Scale bar E-F = 200µm; G-H = 25µm
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aggregates are shown in all cases to indicate complete absence of endothelial marker staining.
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Tumor-derived angiogenic expression is a function 
of the 3D microenvironment in vitro
To examine whether angiogenic expression is 
exclusively a hypoxia-driven event independent of the 
5&&6.16DQG8PRQROD\HUFHOOVZHUHFXOWXUHG
XQGHU K\SR[LF FRQGLWLRQV  2
2




) monolayer cultures. The majority of 
DQJLRJHQLFUHODWHGJHQHVGLGQRWGHPRQVWUDWHVLJQL¿FDQWO\
upregulated expression in hypoxia monolayer culture 
UHODWLYHWRQRUPR[LFPRQROD\HUFXOWXUHIRUERWK.16
DQG8FHOOVZKHUHDVVHYHUDOJHQHVZHUHVLJQL¿FDQWO\
Figure 7: GBM cells develop morphological features of endothelial cells when cultured under endothelial-promoting 
conditions in vitro. A.'LVWLQFWHQGRWKHOLDOOLNHWXEXODUVWUXFWXUHVFRPSULVHGRI.16FHOOVXQGHUQRUPR[LDR[\JHQB. Better 
VWUXFWXUDOO\GH¿QHGWXEXOHVZKHQK\SR[LDK\SR[LDLVLQGXFHGXVLQJ')2EXWQRWVLJQL¿FDQWO\GLIIHUHQWLQPHDQQXPEHU
(pUHODWLYHWRXQWUHDWHGQRUPR[LFFXOWXUHVC. Moderate impairment of tubular structures upon VEGF inhibition, with 
VLJQL¿FDQWUHGXFWLRQLQPHDQWXEXOHQXPEHUWXEXOHVp < 0.05) relative to untreated cultures. (D-E) Pronounced impairment 
RIFORVHGWXEXODUVWUXFWXUHVDQGUHGXFWLRQRIWXEXOHQXPEHUXSRQ)*)5LQKLELWLRQp < 0.05) and dual VEGF / FGFR inhibition 
   p < 0.01). F. ([SRVXUH WR '062 DORQH )*)5 LQKLELWRU YHKLFOH GRHV QRW LPSDLU WXEXOH IRUPDWLRQ ZLWK QR VLJQL¿FDQW
GLIIHUHQFHLQPHDQWXEXOHQXPEHUp < 0.05) relative to untreated normoxia cultures. Representative images were taken 48 
KRXUVSRVWVHHGLQJDQGSRVWH[SRVXUHWRLQKLELWRUV6FDOHEDU P.
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upregulated under normoxia (p < 0.001) (Figure 8A and 
& UHVSHFWLYHO\ )RU ERWK .16 DQG 8 FHOOV WKH
PDMRULW\RIDQJLRJHQLFUHODWHGJHQHVZHUHVLJQL¿FDQWO\
XSUHJXODWHGLQ'5&&6FXOWXUHUHODWLYHWR'K\SR[LF
culture (p < 0.001) (Figure 8B and 8D respectively). No 
JHQHZDV VLJQL¿FDQWO\XSUHJXODWHG LQ8'K\SR[LD
FXOWXUH )LJXUH ' DQG RQO\ ,' ZDV VLJQL¿FDQWO\
XSUHJXODWHG LQ.16'K\SR[LDFXOWXUH p < 0.001) 
)LJXUH%7KHVH¿QGLQJVVXJJHVW WKDWK\SR[LDDORQH
within the RCCS environment per se does not trigger VM 
and a tumor-derived angiogenic response in GBM cells 
in vitro.
DISCUSSION
The induced expression of the endothelial markers 
&'&'DQGY:)LQ+**FHOOVZLWKLQWKHG\QDPLF
RCCS was typically observed at the interface between the 
necrotic core of the aggregate and highly cellular rim. As 
we have previously showed that this region is hypoxic 
EXW YLDEOH >@ RXU ¿QGLQJ LV FRQVLVWHQW ZLWK VWXGLHV
indicating that hypoxia is a key microenvironmental cue 
promoting the microvascular niche. Furthermore, culture 
conditions promoting endothelial proliferation enhanced 
the TDEC phenotype in glioma cells with respect to 
tubular structure formation in Matrigel and which was 
Figure 8: GBM cells exhibit tumor-derived angiogenic expression as a consequence of a 3D microenvironment in vitro. 
Volcano plots of angiogenesis array quantitative RT-PCR with a log2 fold difference on x-axis and p-value on y-axis. Horizontal blue line 





















angiogenesis-related genes in hypoxic monolayers.
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moderately more distinct under hypoxic strain. However 
RXUUHVXOWVLQGLFDWHWKDWK\SR[LDDORQHZDVLQVXI¿FLHQWWR
induce VM-related and tumor-derived angiogenic changes 
in monolayer cultures, but rather that the key trigger in the 
context of our experiments was the three-dimensionality of 
the RCCS and Matrigel cultures. This implies that cellular 
interaction is an important determinant of tumor-derived 
VM in our culture systems and which may be potentiated 
by induced hypoxic strain as observed in the tubule-
IRUPLQJ DVVD\ 7KLV ¿QGLQJ LV FRQVLVWHQW ZLWK D UHSRUW
RIK\SR[LFSURPRWLRQRI90LQD'RYDULDQFDUFLQRPD
culture model [26].
:H GHPRQVWUDWH &'  &' 7'(& FR
expression and VM structures in U87 xenografts in vivo 
DQG &'  *)$3 DQG &'  *)$3 FRORFDOL]DWLRQ
in primary HGG tissue consistent with previous studies 
>@DOEHLWRXULQWHUSUHWDWLRQLVOLPLWHGWRDÀDQNPRGHO
rather than orthotopic brain. This is evidence against the 
possibility that TDEC and VM are simply a function 
unique to the RCCS, but rather support the notion that 
these are distinct biological processes that may contribute 
to neo-vascularization within primary HGG tissue. The 
importance of endothelial-like cells to tumor growth may 
be best understood in the creation of stimulatory cell-
cell contacts in the peri-vascular niche, as opposed to the 
creation of a functional vasculature. This has previously 
been suggested by the observation of increased growth of 
JOLRPDFHOOVFRFXOWXUHGZLWKHQGRWKHOLDOFHOOV:HKDYH
previously documented that co-localization of brain tumor 
and endothelial markers frequently occurs in peri-necrotic 
regions of primary HGG and that CD105 expression is 
an indicator of poor prognosis in a cohort of pediatric 
HGG (n = 150) [27]. Our data suggests that the presence 
of necrotic cells may stimulate tumor cells to acquire a 
TDEC phenotype. Glioma cell / endothelial cell co-
cultured aggregates displayed a greatly altered pattern of 
gene expression compared to glioma-only aggregates, with 
many of the genes putatively implicated in VM including 
127&+ 7*)ȕ +*) DQG &' EHLQJ VLJQL¿FDQWO\
downregulated. One explanation for this may be that 
LQ WKH SUHVHQFH RI VXI¿FLHQW SUHH[LVWLQJ HQGRWKHOLDO
cells there is less of a selective pressure for glioma 
cells to transdifferentiate to TDEC and undergo VM. It 
is plausible that the transdifferentiation of TDEC under 
hypoxic conditions is in part due to a lack of endothelial 
precursors with which to re-constitute the neo-vascular 
niche. Several angiogenesis-related molecules such as 
/DPLQLQ 1HXURSLOLQ DQG &' KDYH EHHQ UHSRUWHG
to be enriched in glioma stem cells capable of forming 
vascular structures in vitro [8], implicating that TDEC 
transdifferentiation is facilitated by a glioma stem-like 
phenotype.
The signaling pathway(s) by which TDEC and 
90HPHUJHDUHVWLOOXQGHU LQYHVWLJDWLRQ:HVKRZWKDW
endothelial markers are expressed in ESC aggregates 
DQG16&DJJUHJDWHVZKLFKRYHUH[SUHVV2&7EXWQRW
ZLOGW\SH 16& 7KLV ¿QGLQJ LPSOLHV WKDW DQ LQGXFHG
pluripotent-like state is necessary to generate VM in 
QRUPDO OLQHDJHUHVWULFWHG QHXUDO FHOOV ZKHUHE\ 2&7
overexpression is necessary for CD105 expression in NSC. 
An association between genes linked to an undifferentiated 
embryonic-like phenotype and VM-positive tissues has 
been reported in VM studies from aggressive melanoma 
>@2XU¿QGLQJVXJJHVWVWKDW90LQEUDLQWXPRUFHOOV
recapitulates a process that relies on pluripotent-like 
features, perhaps similar to an embryonic-like process 
that originates in the transformed neural precursor cells. 
7KHH[SUHVVLRQRIHQGRWKHOLDOPDUNHUVLQOLQHDJHGH¿QHG
16& XSRQ IRUFHG 2&7 H[SUHVVLRQ VXJJHVWV D VLPLODU
process could potentially underlie the ability of cancer 
cells to undergo the same change, whereby some glioma 
cells under selection pressure at least transiently revert to 
a primitive glioma stem cell state, prior to exerting tumor-
derived phenotypes.
Several angiogenesis-related genes were 
upregulated within glioma RCCS cultures in comparison 
to monolayer cultures, including components of the 
)*) DQG 7*)ȕ VLJQDOLQJ SDWKZD\V VXJJHVWLQJ WKDW
these factors are mediators of VM that may be targeted 
WKHUDSHXWLFDOO\,QGHHGGRZQUHJXODWLRQRI7*)ȕLQ*%0
U251 cells abrogates the ability to form VM-associated 
tubular structures on Matrigel with an associated decline 
LQ003DFWLYLW\>@7KH3,NLQDVHQHWZRUNPHGLDWHG
by MMP-2 upregulation has previously been implicated 
LQPHODQRPD90>@FRQVLVWHQWZLWKRXUREVHUYDWLRQ
that MMP-2 was one of the most downregulated 
genes in response to FGFR or VEGF inhibition. Other 
metalloproteinases, e.g. MMP-9, were among the genes 
PRVW XSUHJXODWHG E\ 5&&6 ' FXOWXUH FRQVLVWHQW
ZLWK D VLJQL¿FDQW DVVRFLDWLRQ EHWZHHQ90 DQG 003
 H[SUHVVLRQ LQ FOLQLFDO JOLRPD VSHFLPHQV >@ DQG
LQ WXPRU  HQGRWKHOLD FRFXOWXUHV >@ ,W LV SODXVLEOH
therefore that VM may be associated with the aggressive 
and invasive nature of gliomas. The remodeling of ECM 
has been shown to provide the space needed for VM and 
LV UHJXODWHG E\ PHWDOORSURWHLQDVHV >@ 7KHUHIRUH WKH
upregulation and secretion of endogenous ECM we have 
SUHYLRXVO\REVHUYHG LQ5&&6DJJUHJDWHV>@FRXSOHG
with the upregulation of metalloproteinases shown in 
this study, suggests that ECM remodeling may precede 
VM formation and glioma-derived endothelial marker 
expression. 
Our results suggest that small molecule inhibitors 
that competitively bind to VEGF and FGFR both have 
an effect in abrogating the development of VM, though 
FGFR may have a more fundamental role. Approaches 
such as the monoclonal antibody bevacizumab that target 
free VEGF ligand may have a limited inhibitory effect on 
DQJLRJHQHVLVLI)*)5GHSHQGHQW90SOD\VDVLJQL¿FDQW
role. Although TDEC failed to express VEGFR in one 
study, others have reported that VEGFR2 is expressed 
RQWKHVHFHOOV>@%ORFNDGHRI9(*)OLJDQGRUJHQH
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silencing of VEGFR2 appears to inhibit the differentiation 
of tumor endothelial progenitors into endothelium, but not 
the differentiation of glioma stem-like cells into immature 
tumor endothelial progenitors [6]. Similarly, glioma stem-
like cells formed a higher number of vascular structures 
in a tubule-forming assay and preferentially expressed 
high levels of VEGFR2 (relative to parental GBM cells), 
which was abrogated upon targeting of VEGFR2 using 
DPRQRFORQDODQWLERG\ >@7KLV¿QGLQJVXJJHVWV WKDW
the VEGF-dependent upregulated angiogenic response, 
endothelial marker expression and vascular structure 
formation observed in our study, may be due to a VEGF-
mediated role in the maturation of TDEC. As VEGF 
inhibition still resulted in a reduction of endothelial 
markers, our results also imply that the differentiation 
of a proportion of glioma cells into TDEC in the RCSS 
may be VEGF-dependent. However, branching network 
formation and gene expression of endothelial markers 
was more strongly abrogated by FGFR inhibition in our 
study, suggesting that FGF signaling may be functionally 
more relevant to glioma VM, at least in the context of our 
model. Studies concerning VM in glioma have not yet 
DGGUHVVHGWKHGLUHFWFOLQLFDOVLJQL¿FDQFHRIWKLVSURFHVVLQ
the course of tumor initiation, progression and recurrence. 
Anti-angiogenic therapy trials may be required to consider 
VM as a possible mechanism of therapeutic failure, as 
TDEC often do not express the same levels of receptors 
that ERQD¿GH endothelial cells display.
The RCCS provides a practical way of modeling 
90 ZLWKLQ D KXPDQVSHFL¿F PRGHO in vitro, allowing 
for biological manipulation and investigation of this 
potentially important mechanism of resistance to anti-
DQJLRJHQLF WKHUDS\ 7R RXU NQRZOHGJH WKLV LV WKH ¿UVW
report of TDEC and VM in a 'JOLRPDFXOWXUHPRGHO
The investigations presented here suggest that FGFR plays 
DVLJQL¿FDQWUROHLQ90EXWWKDW9(*)2&7DQGRWKHU
pathways also play important roles and that the process 
is intrinsically linked to cell-to-cell interaction within 
D ' FRQWH[W K\SR[LD DQG QHFURVLV 3KDUPDFRORJLFDO
intervention in the RCCS in comparison to rodent 
orthotopic models will be required to further validate 
WKH5&&6DQGLQGHHGDOWHUQDWLYH'FXOWXUHPRGHOVDV
a surrogate to study and therapeutically manipulate VM. 
Further work will undoubtedly reveal a more complex 
molecular basis of VM and elucidate the therapeutic 
potential of targeting VM in malignant tumors.
MATERIALS AND METHODS
Monolayer and RCCS cultures
.16 SHGLDWULF *%0 >@ DQG 5HV >@
(pediatric ependymoma) were maintained in Dulbeccos 
PRGL¿HG(DJOH¶VPHGLXP'0(0),QYLWURJHQ
U87 (adult GBM), T7 / 11 (adult primary GBM) and GB-1 
(pediatric mixed glial-neuronal grade III tumor, previously 
GHVFULEHGE\XV>@LQ'0(0,QYLWURJHQ(7*$
(mouse ESC) in Glasgow minimal essential medium 
6LJPD+%0(&>@EUDLQPLFURYDVFXODUHQGRWKHOLDO
cells) in Roswell Park Memorial Institute (RPMI) medium 
6LJPDDQGSRVWQDWDOGD\PRXVH16&ZLWK2FW
over-expression in B27 / N2 / DMEM / F12 neurobasal 
PHGLXP 16& ZLWK WKH 2FW WUDQVJHQH ZDV JHQHUDWHG
as described [19]. All media were supplemented with 
 IHWDO ERYLQH VHUXP H[FHSW +%0(& ZKLFK ZDV
VXSSOHPHQWHG ZLWK  IHWDO ERYLQH VHUXP $ 
WXPRUHQGRWKHOLDO UDWLR PHGLD ZDV XVHG DV FRFXOWXUH
PHGLD'5&&66\QWKHFRQ/X[HPERXUJFXOWXUHZDV
commenced by introducing 1 x 106 cells as a single cell 
suspension into a 10 ml rotating vessel containing media as 
per monolayer cultures. Once a visible aggregate formed 
(typically by 1-2 days), revolution speed was adjusted 
to balance the Coriolis force against gravity in order to 
maintain the aggregate in stationary free-fall. Harvested 
DJJUHJDWHV W\SLFDOO\DIWHUGD\VZHUHHLWKHU¿[HG
LQSDUDIRUPDOGHK\GHRUVWRUHGIUR]HQDW&XQWLO
required for further analysis. Exposure to angiogenic 
inhibitors was achieved by culturing RCCS aggregates in 
PHGLDFRQWDLQLQJHLWKHU0DQWLYDVFXODUHQGRWKHOLDO






analyses, at least three independent RCCS aggregates 
were cultured and harvested. To determine the proportion 
of actively proliferating cells in glioma aggregates upon 
DQWLDQJLRJHQLFWUHDWPHQWD&RXQWHU3HQ&HOO&RXQWHU
9:5,QWHUQDWLRQDO8.ZDVXVHGWRFRXQW.LSRVLWLYH
and Ki67 negative cells from three independent aggregates 
DQGXVLQJHLWKHUDZKROHDJJUHJDWH¿HOGRIYLHZRUWKUHH
GLIIHUHQW¿HOGRIYLHZVIRUHDFKDJJUHJDWH7KHPHDQ
standard error (SEM) percentage of Ki67 positive cells 
relative to total number of cells was calculated.
Pediatric high-grade glioma tissue microarray
Pediatric high-grade gliomas (HGG) were surgically 
collected ante-mortem at UK pediatric neurosurgical 
centers (between 1987 and 2007) and banked by the 
&KLOGUHQ¶V&DQFHU/HXNHPLD*URXS8.&&/*WKURXJK
Nottingham Childrens Brain Tumor Research Centre, 
ZLWKGLDJQRVLVFRQ¿UPHGE\FHQWUDOSDWKRORJLFDOUHYLHZ
The project has ethics (UK ethics/R&D number PO 
059801 and OG 080002) and Biobank approval (11/




Standard immunohistochemistry procedure [20] 
ZDV IROORZHG ZLWK WKH IROORZLQJ DQWLERG\ GLOXWLRQV
DQWL.L'DNRFORQH0L%DQWL&''DNR
FORQH -&$  DQWL&' $EFDP DE
 DQWLY:)  $EFDP DE 6WDQGDUG
LPPXQRÀXRUHVFHQFHZDVIROORZHGZLWKSULPDU\DQWLERG\






OLJKW PLFURVFRSH ¿WWHG ZLWK D +DPDPDWVX 2&5$(5
FDPHUDXVLQJWKUHHÀXRUHVFHQWOLJKW¿OWHUV)RU.16FHOO
FXOWXUHVXQGHUJRLQJ+\SR[\SUREH+\SR[\SUREH,QF
%XUOLQJWRQ 0$ DQDO\VLV WKH +\SR[\SUREH UHDJHQW
(pimonidazole) was applied two hours before harvesting 
DW  0 FRQFHQWUDWLRQ 6DPSOHV ZHUH WKHQ ¿[HG DV




detection and representative qualitative images taken from 
¿YHVOLGHV
Array quantitative reverse transcriptase (RT)-
PCR
F'1$ZDVV\QWKHVL]HGIURPJWRWDO51$XVLQJ
the RT2 First Strand Kit (SABiosciences) according to 
the standard protocol. Array quantitative RT-PCR was 
performed using the human angiogenesis array (PAHS-
' 6$%LRVFLHQFHV FRQWDLQLQJ  DQJLRJHQHVLV
related genes and according to manufacturer guidelines 
using 96 well plates. The array was run on a CFX96 
%LR5DGLQVWUXPHQWIRUPLQXWHVDW&IROORZHGE\
F\FOHVRI&IRUVHFRQGVDQG&IRURQHPLQXWH
Each cycle was followed by a plate read and CT values 
were calculated for each well in triplicate with each array 
experiment conducted on three independent aggregates or 
three independent monolayer cultures for each line. 
In vivo xenografts
Six nude mice were implanted subcutaneously in 
WKHÀDQNZLWK[6 U87 glioma cells. Tumors were 
KDUYHVWHG DIWHU IRXU ZHHNV JURZWK IRUPDOLQ ¿[HG DQG
SDUDI¿Q HPEHGGHG ,PPXQRKLVWRFKHPLVWU\ DJDLQVW
KXPDQVSHFL¿F YDVFXODU PDUNHUV ZDV XQGHUWDNHQ LQ D
standard fashion. All procedures were in compliance 
ZLWKWKH$QLPDOV6FLHQWL¿F3URFHGXUHV$FWZLWK
mice having access to sterile food and water ad libitum, 
environmental enrichment and ample sterile bedding.
Matrigel tubule formation assay
Endothelial-like tubule formation was assessed 








using a light microscope. Cells were plated in triplicate 
wells and the experiment repeated three times, with 
representative qualitative images taken. To semi-quantitate 
the degree of vessel-like formation, the number of fully-
formed structurally intact tubules, deemed as those with 
closed sides, were counted per well. The mean number of 
tubules +/- SEM was determined from triplicates of three 
independent experiments (n = 9). 
Biostatistics
Analysis of the array quantitative RT-PCR data 
was undertaken using the accompanying Excel based 
VWDWLVWLFDOSDFNDJH6$%LRVFLHQFHVDQGFRQ¿UPHGXVLQJ
6366 LQ RUGHU WR GHWHUPLQH VLJQL¿FDQW IROG FKDQJHV
Gene expression data was presented consistently using 
volcano plots where fold-change was plotted directly 
DJDLQVWVWDWLVWLFDOVLJQL¿FDQFHP-values were considered 
VLJQL¿FDQWDWOHVVWKDQWKURXJKRXW$QLQGHSHQGHQW
student tWHVW 6366ZDVXVHG WRGHWHUPLQHVLJQL¿FDQW
differences in vessel-like tubule formation in the Matrigel 
assay.
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